Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 158

1.

Residual HIV-1 RNA and HIV-1 DNA production in the genital tract reservoir of women treated with HAART: the prospective ANRS EP24 GYNODYN study.

Launay O, Tod M, Tschöpe I, Si-Mohamed A, Bélarbi L, Charpentier C, Goujard C, Taburet AM, Lortholary O, Leroy V, Bélec L; ANRS EP24 GYNODYN Study Group.

Antivir Ther. 2011;16(6):843-52. doi: 10.3851/IMP1856.

PMID:
21900716
2.

Viral excretion in cervicovaginal secretions of HIV-1-infected women receiving antiretroviral therapy.

Debiaggi M, Zara F, Spinillo A, De Santolo A, Maserati R, Bruno R, Sacchi P, Achilli G, Pistorio A, Romero E, Filice G.

Eur J Clin Microbiol Infect Dis. 2001 Feb;20(2):91-6.

PMID:
11305478
3.

Effect of highly active antiretroviral therapy on cervicovaginal HIV-1 RNA.

Cu-Uvin S, Caliendo AM, Reinert S, Chang A, Juliano-Remollino C, Flanigan TP, Mayer KH, Carpenter CC.

AIDS. 2000 Mar 10;14(4):415-21.

PMID:
10770544
4.

Correlates of HIV-1 shedding in cervicovaginal secretions and effects of antiretroviral therapies.

Fiore JR, Suligoi B, Saracino A, Di Stefano M, Bugarini R, Lepera A, Favia A, Monno L, Angarano G, Pastore G.

AIDS. 2003 Oct 17;17(15):2169-76.

PMID:
14523273
5.

Persistent genital tract HIV-1 RNA shedding after change in treatment regimens in antiretroviral-experienced women with detectable plasma viral load.

Venkatesh KK, DeLong AK, Kantor R, Chapman S, Ingersoll J, Kurpewski J, De Pasquale MP, D'Aquila R, Caliendo AM, Cu-Uvin S.

J Womens Health (Larchmt). 2013 Apr;22(4):330-8. doi: 10.1089/jwh.2012.3849. Epub 2013 Mar 26.

6.

Antiretroviral drug concentrations and HIV RNA in the genital tract of HIV-infected women receiving long-term highly active antiretroviral therapy.

Kwara A, Delong A, Rezk N, Hogan J, Burtwell H, Chapman S, Moreira CC, Kurpewski J, Ingersoll J, Caliendo AM, Kashuba A, Cu-Uvin S.

Clin Infect Dis. 2008 Mar 1;46(5):719-25. doi: 10.1086/527387.

7.

Selection of drug-resistant variants in the female genital tract of human immunodeficiency virus type 1-infected women receiving antiretroviral therapy.

Si-Mohamed A, Kazatchkine MD, Heard I, Goujon C, Prazuck T, Aymard G, Cessot G, Kuo YH, Bernard MC, Diquet B, Malkin JE, Gutmann L, Bélec L.

J Infect Dis. 2000 Jul;182(1):112-22. Epub 2000 Jul 6.

8.

Antiretroviral treatment interruptions predict female genital shedding of genotypically resistant HIV-1 RNA.

Graham SM, Jalalian-Lechak Z, Shafi J, Chohan V, Deya RW, Jaoko W, Mandaliya KN, Peshu NM, Overbaugh J, McClelland RS.

J Acquir Immune Defic Syndr. 2012 Aug 15;60(5):511-8. doi: 10.1097/QAI.0b013e31825bd703.

9.

Human immunodeficiency virus type 1-related nucleic acids and papillomavirus DNA in cervicovaginal secretions of immunodeficiency virus-infected women.

Spinillo A, Debiaggi M, Zara F, De Santolo A, Polatti F, Filice G.

Obstet Gynecol. 2001 Jun;97(6):999-1004.

PMID:
11384710
10.

Herpes simplex virus type 2 (HSV-2) genital shedding in HSV-2-/HIV-1-co-infected women receiving effective combination antiretroviral therapy.

Péré H, Rascanu A, LeGoff J, Matta M, Bois F, Lortholary O, Leroy V, Launay O, Bélec L; ANRS EP24 study group.

Int J STD AIDS. 2016 Mar;27(3):178-85. doi: 10.1177/0956462415577727. Epub 2015 Mar 13.

PMID:
25769886
11.

HIV-DNA in the genital tract of women on long-term effective therapy is associated to residual viremia and previous AIDS-defining illnesses.

Prazuck T, Chaillon A, Avettand-Fènoël V, Caplan AL, Sayang C, Guigon A, Niang M, Barin F, Rouzioux C, Hocqueloux L.

PLoS One. 2013 Aug 21;8(8):e69686. doi: 10.1371/journal.pone.0069686. eCollection 2013.

12.

Effect of HSV-2 suppressive therapy on genital tract HIV-1 RNA shedding among women on HAART: a pilot randomized controlled trial.

Nijhawan AE, Delong AK, Chapman S, Rana A, Kurpewski J, Ingersoll J, Caliendo AM, Cu-Uvin S.

Infect Dis Obstet Gynecol. 2012;2012:868526. doi: 10.1155/2012/868526. Epub 2012 Feb 28.

13.

Cervicovaginal HIV-1 shedding in women taking antiretroviral therapy in Burkina Faso: a longitudinal study.

Low AJ, Konate I, Nagot N, Weiss HA, Kania D, Vickerman P, Segondy M, Mabey D, Pillay D, Meda N, van de Perre P, Mayaud P; Yerelon Study Group.

J Acquir Immune Defic Syndr. 2014 Feb 1;65(2):237-45. doi: 10.1097/QAI.0000000000000049.

14.

Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.

Van Vaerenbergh K.

Verh K Acad Geneeskd Belg. 2001;63(5):447-73. Review.

PMID:
11813503
15.

Independent levels of cell-free and cell-associated human immunodeficiency virus-1 in genital-tract secretions of clinically asymptomatic, treatment-naive African women.

Andréoletti L, Chomont N, Grésenguet G, Matta M, de Dieu Longo J, Carreno MP, Si-Mohamed A, Legoff J, Kazatchkine MD, Bélec L.

J Infect Dis. 2003 Aug 15;188(4):549-54. Epub 2003 Jul 29.

16.

HIV-1 DNA and RNA kinetics in primary HIV infection.

Lillo F, Grasso M, Lodini S, Capiluppi B, Lazzarin A, Tambussi G.

J Biol Regul Homeost Agents. 2002 Jan-Mar;16(1):49-52.

PMID:
12003174
17.

Directly observed antiretroviral therapy to reduce genital tract and plasma HIV-1 RNA in women with poor adherence.

Harwell JI, Flanigan TP, Mitty JA, Macalino GE, Caliendo AM, Ingersoll J, Stenzel MS, Carpenter CC, Cu-Uvin S.

AIDS. 2003 Sep 5;17(13):1990-3.

PMID:
12960835
18.

Differences in HIV-1 pol sequences from female genital tract and blood during antiretroviral therapy.

De Pasquale MP, Leigh Brown AJ, Uvin SC, Allega-Ingersoll J, Caliendo AM, Sutton L, Donahue S, D'Aquila RT.

J Acquir Immune Defic Syndr. 2003 Sep 1;34(1):37-44.

PMID:
14501791
19.

Early archives of genetically-restricted proviral DNA in the female genital tract after heterosexual transmission of HIV-1.

Chomont N, Hocini H, Grésenguet G, Brochier C, Bouhlal H, Andréoletti L, Becquart P, Charpentier C, de Dieu Longo J, Si-Mohamed A, Kazatchkine MD, Bélec L.

AIDS. 2007 Jan 11;21(2):153-62.

PMID:
17197805
20.

Long-term suppression of plasma viremia with highly active antiretroviral therapy despite virus evolution and very limited selection of drug-resistant genotypes.

Pariente N, Pernas M, de la Rosa R, Gómez-Mariano G, Fernández G, Rubio A, López M, Benito JM, López-Galíndez C, Leal M, Domingo E, Martinez MA, Mas A.

J Med Virol. 2004 Jul;73(3):350-61.

PMID:
15170628
Items per page

Supplemental Content

Write to the Help Desk